author-photo

Susan Arthur

18

Papers

288

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

FC 024SAFETY AND EFFICACY OF PATIROMER FOR HYPERKALAEMIA IN PATIENTS WITH STAGE 1-3A OR STAGE 3B-5 CHRONIC KIDNEY DISEASE: POOLED ANALYSIS OF THE AMETHYST-DN, OPAL-HK AND TOURMALINE TRIALS

2021 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
PATIROMER VS PLACEBO TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CKD: ANALYSIS ACCORDING TO PATIENT SEX (AMBER TRIAL)

2021 Journal of Hypertension
Show All
- Source
- Cite
- Save
Citations (0)
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes.

2021 Clinical Journal of The American Society of Nephrology
Show All
- Source
- Cite
- Save
Citations (0)
1054-P: Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Diabetes

2020 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
SO033PATIROMER TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CHRONIC KIDNEY DISEASE (AMBER): PRESPECIFIED RESULTS BY BASELINE SERUM POTASSIUM

2020 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure.

2020 European Journal of Heart Failure
Show All
- Source
- Cite
- Save
Citations (5)
1118-P: Effect of Patiromer in Patients 75 Years or Older with Diabetic Kidney Disease and Hyperkalemia Receiving a RAAS Inhibitor

2019 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
OS 19-04 CHRONIC DIURETIC THERAPY DOES NOT IMPAIR THE EFFECTIVENESS OF PATIROMER IN HYPERKALEMIC PATIENTS WITH CKD.

2016 Journal of Hypertension
Show All
- Source
- Cite
- Save
Citations (0)
Patiromer increased time to RAAS inhibitor discontinuation compared with placebo in advanced CKD patients with hyperkalemia

2015 Journal of The American Society of Hypertension
Show All
- Source
- Cite
- Save
Citations (2)
Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

2004 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (38)